STarting incrEmental Prescription of Peritoneal Dialysis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Queensland
About this trial
Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially harmful. The STEP-PD trial aims to determine the optimal approach to commencing patients on PD through starting at low dose PD and incrementing over time.
Eligibility criteria
Qualifiers
adults (≥18 years) commencing PD as their first dialysis therapy (and been on dialysis for <1 month)
able to give informed consent
Disqualifiers
urine output <0.5L/day
previous kidney transplant
unlikely to be on dialysis for ≥1 year.
known or planned pregnancy during the trial
Trial design
Treatments tested in this trial
- Incremental PD
- Full dose PD
Treatment groups
224 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov